NNW Headlines
Save 20% on Press Releases and More with NNW Prime! Click to View Details
Home » NewsRoom » NewsRoom Articles
MondayMar 13, 2017 4:30 pm

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) Starts Presentation at 29th Annual Roth Conference

Sorrento Therapeutics (NASDAQ: SRNE) is a biopharmaceutical company that focuses on the discovery, acquisition, development and commercialization of proprietary drug therapeutics for addressing unmet medical needs worldwide. The company’s primary therapeutic focus is oncology, including the treatment of chronic cancer pain, as well as developing therapeutic products for other indications, such as immunology and infectious diseases. It is developing resiniferatoxin, a non-opiate, ultra-potent, and selective agonist of the TRPV-1 receptor for intractable pain in end-stage disease. For more information, visit the company’s website at www.sorrentotherapeutics.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a…

Continue Reading

MondayMar 13, 2017 4:30 pm

Cempra, Inc. (NASDAQ: CEMP) Starts Presentation at 29th Annual ROTH Conference

Cempra (NASDAQ: CEMP) is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases. Cempra's two lead product candidates are currently in advanced clinical development. Solithromycin has been evaluated in two phase 3 clinical trials for community-acquired bacterial pneumonia. Cempra is currently seeking approval for both intravenous and oral capsule formulations from the U.S. Food and Drug Administration and the European Medicines Agency. Solithromycin is also in a phase 3 clinical trial for uncomplicated urogenital urethritis caused by Neisseria gonorrhoeae or chlamydia. The company’s second product candidate, Fusidic acid, has completed enrollment…

Continue Reading

MondayMar 13, 2017 4:30 pm

Columbus McKinnon Corp. (NASDAQ: CMCO) Starts Presentation at 29th Annual ROTH Conference

Columbus McKinnon (NASDAQ: CMCO) designs, manufactures, and markets material handling products for various commercial and industrial end-user markets in the United States and internationally. The company offers material handling products, technologies, systems and services, which efficiently and ergonomically move, lift, position and secure materials and people. Key products include hoists, cranes, actuators, rigging tools, light rail work stations and digital power and motion control systems. The company sells its products to various industries such as manufacturing, power generation and distribution, utilities, wind power, warehouses, commercial construction, oil and gas exploration and refining, petrochemical, marine, ship building, transportation and heavy duty…

Continue Reading

MondayMar 13, 2017 4:30 pm

AxoGen, Inc. (NASDAQ: AXGN) Starts Presentation at 29th Annual ROTH Conference

AxoGen (NASDAQ: AXGN) is engaged in innovative surgical solutions for peripheral nerve injuries. AxoGen's portfolio of products includes Avance®Nerve Graft, AxoGuard® Nerve Connector, AxoGuard® Nerve Protector, and Avive™ Soft Tissue Membrane. Along with these core surgical products, the company also offers AxoTouch™ Two-Point Discriminator and AcroVal™ Neurosensory & Motor Testing System. These evaluation and measurement tools assist health care professionals in detecting changes in sensation, assessing return of sensory, grip, and pinch function, evaluating effective treatment interventions, and providing feedback to patients on nerve function. The AxoGen portfolio of products is available in the United States, Canada, the United Kingdom, and several European and international…

Continue Reading

MondayMar 13, 2017 4:30 pm

Upland Software, Inc. (NASDAQ: UPLD) Starts Presentation at 29th Annual Roth Conference

Upland Software (NASDAQ: UPLD) provides cloud-based enterprise work management software in the United States and internationally. It offers a family of cloud-based enterprise work management software applications under the Upland brand for the information technology, process excellence, finance, professional services, and marketing functions in organizations. The company’s software applications address enterprise work challenges in various categories, including program and portfolio management, project management and collaboration, workflow automation and enterprise content management, digital engagement management, professional services automation, and financial management. It sells its products through a direct sales organization, as well as through distributors and value-added resellers. For more information,…

Continue Reading

MondayMar 13, 2017 4:00 pm

FORM Holdings Corp. (NASDAQ: FH) Starts Presentation at 29th Annual ROTH Conference

FORM Holdings Corp. (NASDAQ: FH) is a diversified holding company that specializes in identifying, investing in and developing companies with superior growth potential.  FORM's current holdings include Group Mobile, FLI Charge, Infomedia and intellectual property assets. Group Mobile is a provider of rugged, mobile and field-use computing products, serving customers worldwide. FLI Charge designs, develops, licenses, manufactures and markets wireless conductive power and charging solutions. Infomedia is a provider of customer relationship management and monetization technologies to mobile carriers and device manufacturers. FORM Holdings' intellectual property division is engaged in the development and monetization of intellectual property. For more information, visit the company’s…

Continue Reading

MondayMar 13, 2017 4:00 pm

Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) Starts Presentation at 29th Annual ROTH Conference

Hanwha Q CELLS (NASDAQ: HQCL) is a global photovoltaic manufacturer known for its high-performance, high-quality solar cells and modules. It is headquartered in Seoul, South Korea (Global Executive HQ) and Thalheim, Germany (Technology & Innovation HQ) with diverse international manufacturing facilities in Malaysia and China. Hanwha Q CELLS offers the full spectrum of photovoltaic products, applications and solutions, from modules to kits to systems to large-scale solar power plants. Through its growing global business network spanning Europe, North America, Asia, South America, Africa and the Middle East, the company provides services and long-term partnership to its customers in the utility, commercial, government and residential markets. Hanwha Q CELLS is a flagship company of Hanwha…

Continue Reading

MondayMar 13, 2017 4:00 pm

Lydall, Inc. (NYSE: LDL) Starts Presentation at 29th Annual ROTH Conference

Lydall (NYSE: LDL) designs, manufactures and markets specialty engineered filtration media, industrial thermal insulating solutions, and automotive thermal and acoustical barriers for filtration/separation and thermal/acoustical applications worldwide. The Performance Materials segment offers filtration media solutions for air, fluid power and industrial applications. The Technical Nonwovens segment offers non-woven felt media and filter bags for industrial air and liquid filtration applications. The Thermal/Acoustical Metals segment provides engineered products for the transportation sector to thermally shield sensitive components from high heat, improve exhaust gas treatment, and lower harmful emissions, as well as assist to reduce powertrain and road noise. For more information,…

Continue Reading

MondayMar 13, 2017 4:00 pm

CEVA, Inc. (NASDAQ: CEVA) Starts Presentation at 29th Annual ROTH Conference

CEVA (NASDAQ: CEVA) licenses signal processing intellectual property (IP) technologies. The company partners with semiconductor companies and OEMs worldwide to create power-efficient, intelligent and connected devices for a range of end markets including mobile, consumer, automotive, industrial and IoT. CEVA’s ultra-low-power IPs for vision, audio, communications and connectivity include comprehensive DSP-based platforms for LTE/LTE-A/5G baseband processing in handsets, infrastructure and machine-to-machine devices, advanced imaging, computer vision and deep learning for any camera-enabled device, audio/voice/speech and ultra-low power always-on/sensing applications for multiple IoT markets. CEVA also offers the industry's most widely adopted IPs for bluetooth, Wi-Fi and serial storage. For more…

Continue Reading

MondayMar 13, 2017 4:00 pm

Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) Starts Presentation at 29th Annual Roth Conference

Zynerba Pharmaceuticals (NASDAQ: ZYNE) is a specialty pharmaceutical company that focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. The company’s product candidates include ZYN002, which is in Phase I clinical trial for the treatment of refractory epilepsy, Fragile X syndrome, and osteoarthritis; and ZYN001 that is in preclinical stage for the treatment of fibromyalgia and peripheral neuropathic pain. For more information, visit the company’s website at www.zynerba.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

NetworkNewsWire

1108 Lavaca St
Suite 110-NNW
Austin, TX 78701
(512) 354-7000

NetworkNewsWire is powered by IBNAi

Copyright . NetworkNewsWire® / 1108 Lavaca St Suite 110-NNW Austin, TX 78701 (512) 354-7000 / Disclaimers